期刊文献+

结节性硬化症合并心脏横纹肌瘤15例临床分析 被引量:4

Clinical analysis of 15 pediatric patients with tuberous sclerosis complex complicated by cardiac rhabdomyomas
原文传递
导出
摘要 目的:研究结节性硬化症(TSC)相关的心脏横纹肌瘤(CRM)的临床特点。方法收集15例合并CRM的TSC患儿的临床资料,分析其临床特征及基因突变结果。结果11例(73%)患儿为多发CRM,肿瘤绝大部分位于左右心室,在心脏彩超上显示多数呈类圆形强回声团,边界清晰。3例患儿出现心律失常,2例发生心力衰竭。2例患儿行基因检测,均检测到TSC基因致病性突变,分别为TSC1基因和TSC2基因突变。随访3例患儿(随访时间6个月-3年2个月),其CRM均自发缩小或消退。结论 TSC患儿合并CRM多为多发,部分患儿可出现心力衰竭及心律失常。心脏彩超是发现CRM的重要方法。CRM可能有自然消退的倾向。TSC基因检测可在分子遗传学上确诊TSC。 ObjectiveTo investigate the clinical features in children with tuberous sclerosis complex (TSC)-associated cardiac rhabdomyomas (CRM).MethodsThe clinical data of 15 children with TSC complicated by CRM were collected. The clinical features of the patients were analyzed, and TSC gene mutations were detected.Results Eleven cases (73%) developed multiple CRM. The majority of the tumors were located in the left and right ventricles. Most tumors presented as a round-like hyperechogenic mass with a clear margin on echocardiography. Arrhythmias occurred in 3 patients and 2 patients experienced heart failure. Gene mutation tests were performed in 2 patients, and pathogenic mutations were detected in both patients, which were TSC1 mutation and TSC2 mutation, respectively. Three patients were followed up for 6 to 38 months, and their CRM shrank or regressed spontaneously.ConclusionsTSC-associated CRM is generally multiple. Heart failure and arrhythmias may occur in some patients. Echocardiography is important for diagnosis of CRM. TSC-associated CRM has an inclination to spontaneous regression. TSC can be diagnosed at a molecular genetic level by TSC gene mutation detection.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2015年第5期477-481,共5页 Chinese Journal of Contemporary Pediatrics
基金 2013年广东省中医药局面上项目(编号:20131100)
关键词 心脏横纹肌瘤 结节性硬化症 基因突变 儿童 Cardiac rhabdomyomas Tuberous sclerosis complex Gene mutation Child
  • 相关文献

参考文献18

  • 1Hope N, Darcy AK. Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference[J]. Pediatr Neurol, 2013, 49(4): 243-254.
  • 2van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34[J]. Science, 1997, 277(8): 805-808.
  • 3The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16[J]. Cell, 1993, 75(7): 1305-1315.
  • 4Etuwewe B, John CM, Abdelaziz M. Asymptomatic cardiac rhabdomyoma in neonates: is surgery indicated?[J]. Images Paediatr Cardiol, 2009, 11(2): 1-8.
  • 5Padalino MA, Reffo E, Cerutti A, et al. Medical and surgical management of primary cardiac tumours in infants and children[J]. Cardiol Young, 2014, 24(2): 268-274.
  • 6Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria[J].Child Neurol, 1998, 13(12): 624-628.
  • 7陈俊,莫绪明,左维嵩,张婧,祁雪.小儿心脏横纹肌瘤多普勒超声心动图表现及诊断价值[J].蚌埠医学院学报,2012,37(3):335-337. 被引量:8
  • 8郑淋,金兰中,王芳韵,马桂琴,卫海燕,张鑫,张晓琳.小儿心脏横纹肌瘤的超声心动图诊断及分析其与结节性硬化症的关系[J].中国超声医学杂志,2012,28(9):817-819. 被引量:29
  • 9Jozwiak S, Kotulska K, Kasprzyk-Obara J, et al. Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex[J]. Pediatrics, 2006, 118(4): 1146-1151.
  • 10Kocabas A, Ekici F, Cetin II, et al. Cardiac rhabdomyomas associated with tuberous sclerosis complex in 11 children: presentation to outcome[J]. Pediatr Hematol Oncol, 2013, 30(2): 7l-79.

二级参考文献45

  • 1赵玉武,孙晓江,郑惠民,丁素菊.结节性硬化症不同年龄的临床特点及婴幼儿特征[J].同济大学学报(医学版),2007,28(3):82-85. 被引量:13
  • 2Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria [ J ]. J Child Neurol, 1998, 13(12) :624-628.
  • 3Kallen K. Hypomotor seizures in infants and children[ J]. Epilepsia, 2002, 43 ( 8 ) : 882-888.
  • 4Roach ES, Sparagana SP. Diagnosis of tuberous sclerosis complex [J]. J Child Neurol, 2004, 19(9) :643-649.
  • 5Schwartz RA, Fern,Sndez G, Kotulska K, Jozwiak S. Tuberous sclerosis complex: advances in diagnosis, genetics, and management [ J ].J Am Acad Dermatol, 2007, 57 (2) : 189-202.
  • 6Curatolo B, Bombardieri R, Cerminara C. Current management for epilepsy in tuberous sclerosis complex [ J ]. Curr Opin Neurol, 2006, 19(2) :119-123.
  • 7Kwan P, Brodie MJ. Early identification of refractory epilepsy [J]. N Engl J Med, 2000, 342(5):314-319.
  • 8Jansen FE, van Huffelen AC, Algra A, van Nieuwenhuizen O. Epilepsy snrgery in tuberous sclerosis: a systematic review [ J]. Epilepsla, 2007, 48(8 ) : 1477-1484.
  • 9Madhavan D, Schaffer S, Yankovsky A, Arzimanoglou A, Renaldo F, Zaroff CM, et al. Surgical outcome in tuberous sclerosis complex : a multicenter survey [ J ]. Epilepsia, 2007, 48 (8) : 1625-1628.
  • 10Jansen FE, Van ltuffelen AC, Van Rijen PC, Leijten FS, Jennekens-Schinkel A, Gosselaar P, et al. Epilepsy surgery in tuberous selerosis : the Dutch experience [ J ]. Seizure, 2007, 16 ( 5 ) :445- 453.

共引文献49

同被引文献25

  • 1Isaacs H Jr. Fetal and neonatal cardiac tumors [ J ]. Pediatr Cardiol, 2004, 25 (3) : 252-273. DOI: I0. 1007/s00246-003- 0590-4.
  • 2Karnak I, Alehan D, Ekinci S, et al. Cardiac rhabdomyoma as an unusual mediastinal mass in a newborn [ J ]. Pediatr Surg Int, 2007, 23(8) :811-814. DOI:10. 1007/s00383~07-1875-0.
  • 3Arnaiz GP, Toledo GI, Borzutzky SA, et al. Cardiac tumors in children and adults: A Multicentric retrospective study ~ J~. RevMed Chil, 2006, 134 ( 9 ): 1135-1145. DOI:/S0034- 98872006000900008.
  • 4Gunther T, Schreiber C, Noebauer C, et al. Treatment strategies for pediatric patients with primary cardiac and pericardia[ tumors: a 30-year review [ J ]. Pediatr Cardiol, 2008, 29 ( 6 ) : 1071- 1076. DOI : 10. 1007/s00246-008-9256-6.
  • 5Tworetzky W, MeElhinney DB, Margossian R, et al. Association between cardiac tumors and tuberous sclerosis in the fetus and neonate [J]. Am J Cardiol, 2003, 92(4):487-489. DOI: 10. 1016/S0002-9149 (03)00677-5.
  • 6Borkowska J, Schwartz RA, Kotulska K, et at. Tuberous sclerosis complex : tumors and tumorigenesis [ J ]. Int J Dermatol, 2011,50 ( 1 ) : 13-20. DOI : 10.1111/j. 1365-4632. 2010. 04727. x.
  • 7Orlova KA, Crino PB. The tuberous sclerosis complex [ J/OL]. Ann N Y Acad Sei, 2010, 1184:87-105. (2010-01) [2016-01- 01 ]. http ://www. ncbi. nlm. nih. gov/pmc/articles/ PMC2892799/ . DOI : 10.1111 !j. 1749-6632. 2009.05117. x.
  • 8Franz DN. Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis [ J]. Expert Rev Anticancer Ther, 2011, 11 (8) :1181-1192. DOI:10. 1586/era. 11.93.
  • 9Curatolo P. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy [J]. Pediatr Neurol, 2015, 52 ( 3 ) :281-289. DOI : 10. 1016/j. pediatrneurol. 2014.10. 028.
  • 10Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference : revised clinical diagnostic criteria [ J ]. J Child Neurol, 1998, 13 ( 12 ) : 624-628. DOI: 10. 1177/ 088307389801301206.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部